Jupiter Hospitals Reports Revenue of 4,564.96 Million Rupees in Second Quarter

Key Facts

Jupiter Life Line Hospitals said revenue from operations reached 4,564.96 million rupees in the second quarter of fiscal 2027, up 15.97% year on year and 11.07% from the previous quarter. The board approved the unaudited results for the quarter and half-year ended September 30, 2026, on October 23, 2026. Total income rose to 4,670.40 million rupees, up 15.35% year on year and 10.79% quarter on quarter. But consolidated net profit fell 1.9% from the year-earlier period to 563.59 million rupees, despite rising 50.2% from the first quarter. The figures show revenue expansion alongside annual pressure on profitability, while net profit improved quarter on quarter.

Revenue from operations was 3,936.29 million rupees in the second quarter of fiscal 2026, compared with 4,109.83 million rupees in the first quarter of fiscal 2027, the two figures underpinning the reported annual and quarterly growth rates. Total income also rose from 4,049.02 million rupees in the year-earlier period to 4,670.40 million rupees, and from 4,215.69 million rupees in the first quarter to its second-quarter level. The company posted an operating margin of 23.4% in the second quarter, the same rate as a year earlier, compared with 19.3% in the first quarter. The margin improvement from the previous quarter reflects a quarterly recovery, without changing the fact that it was unchanged year on year. Net profit was 574.77 million rupees a year earlier, then fell to 563.59 million rupees in the current quarter, after standing at 375.12 million in the first quarter.

Second-quarter revenue comprised 358.5 crore rupees from inpatient services, 77.8 crore from outpatient services and 20.2 crore from other revenue. In the first half of fiscal 2027, total income reached 867.5 crore rupees, up 16.2% from the corresponding period. Earnings before interest, taxes, depreciation and amortization reached 186.2 crore rupees, up 9.1%, while net profit was 93.9 crore. But the EBITDA margin contracted to 21.5%, compared with 22.9% in the first half of fiscal 2026. First-half net profit fell from 101.4 crore rupees to 93.9 crore, with management citing start-up losses at Dombivli, marketing costs, higher depreciation and financing costs as factors weighing on results.

The group’s hospitals recorded an overall occupancy rate of 59.5% in the second quarter, rising to 64.8% excluding Dombivli Hospital. Management said the new hospital’s impact on EBITDA narrowed to a loss of 20 lakh rupees in the second quarter, from 9.5 crore rupees in the first quarter. Management attributed part of the improvement to a seasonal increase in infection cases. The figures come as including Dombivli continues to lower the group’s consolidated occupancy rate compared with the rate excluding it. In the first half, start-up losses attributed to the hospital were 9.7 crore rupees, alongside the other cost factors cited by management.

On expansion plans, management said the Pune South project remains on schedule, with total capital expenditure expected to be about 320 crore rupees and land to be purchased for 150 crore rupees. It added that the Mira Bhayandar project remains at the regulatory stage, with the next phase expected to begin before the end of the fiscal year. The Mumbai business center project remained at the planning stage. Chief Executive Ankit Thacker said the company prefers to own the land on which it builds its hospitals, providing “control, clarity and better financial value over the long term.” The board set a self-imposed debt ceiling of three times EBITDA, and management said the company is currently within that limit.

Management expected radiation therapy operations to begin in the following quarter, after preparations, and organ transplant operations to start within the next two quarters. It also expected to complete CGHS accreditation within 6 to 8 months of the results call and private insurer accreditation in about 12 months. These timelines are part of the operational steps and expansion plans management outlined alongside the first-half results. The Pune South project remains on schedule, according to management, while the Mira Bhayandar project’s move to its next phase depends on completing the regulatory process. Management did not provide a timeline in its statements for completing the Mumbai business center project, which remains at the planning stage.